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ABSTRACT
3D-Printed Fluidic Devices and Incorporated Graphite Electrodes for Electrochemical
Immunoassay of Biomarker Proteins

by
Abdulhameed Alabdulwaheed

Biomarkers are measurable indicators of health status or disease state that can be used for
diagnosis and may help guide patient treatment strategies. Enzyme-linked
immunosorbent assays (ELISA) and other many clinical techniques currently used for
measuring biomarker proteins lack sensitivity, demand high analysis cost, are often not
well-suited for measuring multiple biomarkers in a single sample, and require long
analysis times. Here, we demonstrate simple, low-cost 3D-printed flow-through devices
with integrated electrodes modified with gold nanoparticles (AuNPs) for electrochemical
immunoassays of S100B, a biomarker protein related to conditions like skin cancer and
brain injuries. Flow-through devices are fabricated from photocurable-resin using a
desktop digital light processing (DLP) projector-based 3D printer to produce 500-800 µm
square cross-sectional fluidic channels. Threaded ports at the ends and center of the
channel are included in the device design for connecting commercially available fittings
for fluid delivery and integrating low-cost graphite electrodes for electrochemical
biosensing.
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CHAPTER 1
INTRODUCTION
Protein Biomarkers and Enzyme-Linked Immunosorbent Assays
Biomarkers are measurable indicators of a patient’s health status that can be used for
diagnostic purposes, such as determining disease state or evaluating response to treatment.1 Since
illnesses, infections, and malignancies activate and alter various responses of the immune
system, biomarkers include biomolecules (e.g. proteins, nucleic acids, metabolites, etc.) present
in biological tissues and body fluids.2 For instance, C-reactive protein is a biomarker found in
human serum that gives information about inflammation rates in colon cancer patients to help
assess progression. Another example of a currently trending biomarker protein is transferrin,
which is used to diagnose the rate of iron overload – a major cause of liver cancer.3
Clinical measurements of protein biomarkers are largely based on traditional enzymelinked immunosorbent assay (ELISA).4 ELISA is based on highly specific binding interactions
between the antigen (protein analyte) and antibodies, which are used to isolate the analyte from
the rest of the sample components and/or label the sequestered analyte with a signal-transducing
enzyme. In traditional sandwich-type ELISA, the analyte is first collected from the sample using
antibodies bound on a surface like that of a 96-well microplate (Figure 1). After washing to
remove unbound sample components, a second antibody with an enzyme attached to it is
introduced into the well with the captured antigen. Exposure of the enzyme to its substrate
typically leads to the formation of a product that strongly absorbs visible light, thereby
confirming the presence of analyte.5,6
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Figure 1: Illustrated schematic of a simple sandwich-type ELISA5.7
However, these methods often require relatively long analysis times, relatively large
amounts of sample (~100 µL), substantial technical expertise, and a centralized lab
environment.6,7 Indeed, traditional ELISAs are not compatible with point-of-care-testing (POCT)
and applications in resource-limited settings, which are two major areas of interest in
bioanalytical research. This is due to high cost of the commercially available ELISA kits,
advanced instrumentation requirements, and need for trained personnel.8,9 Moreover, detection
limits of standard ELISA techniques (typically 1-100 pg/mL) are often insufficient for detecting
biomarker proteins during early stages of cancer or in some cases of cancer recurrence when
biomarker levels are low.4 Though studies have found that diagnostics based on multiple
biomarker measurements can give better understanding of patient status than single biomarker
measurements, ELISA is also generally not well-suited for measuring multiple biomarker
proteins simultaneously, Consequently, there is considerable interest in developing novel,
simple, fast, low-cost, and reliable detection strategies for measuring protein biomarkers.10
10

Electrochemical Biosensors
Due to the relatively low costs and lack of maintenance associated with electrochemical
instrumentation, along with simplicity and relative ease of miniaturization, electrochemical
biosensors have emerged as particularly viable technologies for developing new sensors for
biomarker proteins.11,12 Electrochemical biosensors convert a biological recognition event into a
measurable electrochemical signal. Essentially, binding of a protein to a receptor (or an
antibody) or interaction of an enzyme with a substrate is carried out at or near a suitable
electrode surface in a way that causes a change in the potential impedance or produces current
due to the onset of an oxidation or reduction reaction. 11,12
Historically, Heineman and Halsall were the first to develop immunoassays based on
electrochemical detection in the 1980s.13 Various strategies for electrochemical immunosensors
based on electrodes chemically modified with antibodies to capture protein antigen from samples
have been reported. Captured antigen can be labeled with various types of electroactive particles
or enzymes that can produce electroactive species for signal generation and protein
quantitation.12 Heineman’s development of flow-through microfluidic electrochemical
biosensors in the early 2000s represented a particularly noteworthy advance for improving sensor
performance. Compared to ELISA conducted using traditional well plates, electrochemical
biosensing in microfluidics enables compatibility with smaller sample volumes, minimizes
amounts of expensive antibodies and enzymes necessary for the analysis, and offers greater
opportunities for miniaturization and automation.14,15
The Rusling group has recently built on these pioneering concepts of Heineman to
produce ultrasensitive, flow-through electrochemical biosensors for protein biomarkers of
diseases like prostate cancer and oral cancer.16,17 Rusling et al. have developed simple
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polydimethylsiloxane (PDMS) fluidic devices interfaced with electrode arrays. PDMS channels
(made using machined metal molds) are sandwiched between two hard plastic plates. Screenprinted carbon electrode arrays are positioned in the channel and modified with gold
nanoparticles and antibodies. Antigen is collected from the sample in a microcentrifuge tube
using magnetic beads modified with antibodies and an enzyme label. Magnetic beads are
introduced into the fluidic device and those that have bound antigen are immobilized by the
antibody on the electrode surface. Signal is generated by activation of the enzyme and use of a
small diffusible redox species. Multiple proteins can be determined simultaneously with this
system by modifying different electrodes in the same array with appropriate antibodies and
preparing magnetic beads with similarly appropriate antibodies.18
In one study, using this system, Chikkaveeraiah el at. were able to detect interleukin-6
(IL-6) and prostate specific antigen (PSA) at low fg/mL levels in serum samples using flowthrough amperometry as the detection method.18 In another study, Malhotra et al. utilized the
same fluidic device for simultaneous measurement of vascular endothelial growth factor C
(VEGF-C), VEGF, IL-6, and IL-8 in human serum samples as a four-biomarker panel related to
head and neck squamous cell carcinoma (HNSCC). This work showed good correlation to
ELISA results for each cancer biomarker in a cohort of 78 patient samples, though the
electrochemical biosensor required only 5 µL of sample and exhibited 100-1000 times lower
detection limits than the traditional ELISA method.19
While the simple fluidic devices employed by Rusling et al. enabled high sensitivity and
compatibility with low sample volumes, PDMS used for the channels is not well-suited for largescale production or processing outside of research laboratory settings for point-of-care testing
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(POCT).20 As a result, 3D printing has been recently explored by Bishop et al. 21 and
others22,23,24,27,35,49 as an alternative method for preparing fluidic devices.
3D Printing Technology and Fluidic Devices
In 3D printing, a three-dimensional model of the desired object is first designed using
computer-aided design (CAD) software. The design is processed to generate printer instructions
which are sent to the 3D printer. Finally, the 3D printer builds the object by depositing or curing
successive thin layers of material until the desired object is created. Printing material can be
plastic, liquid, powder, or metal.25
Historically, Charles W. Hull was the first to invent 3D printing systems back in the early
1980s as he first fabricated plastic devices by curing successive layers of photopolymers through
a technique called stereolithography (SLA).26 Though 3D printers have been commercially
available since 1988,27 efforts to improve accessibility and affordability of 3D printers began in
the mid-2000s through initiatives like the Rep-Rap project and Fab@Home program, which
created communities aimed at developing and sharing ideas for improving 3D printers.28,30 The
successes of these programs generated interest in 3D printing technology and applications
making 3D printers more affordable.
Several types of 3D printing technologies have been developed. These technologies vary
from one another in the working mechanism and printing materials being used. Printing accuracy
and price are essential features that must be considered. Of the available 3D printing
technologies, printers based on stereolithography (SLA) and fused deposition modeling (FDM)
systems are the most affordable, with desktop printers of these types ranging from a few hundred
to a few thousand dollars. 20 In a recent study, Nordin et al. reported that SLA based on digital
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light processing (DLP) generally exhibits better resolution than other methods for preparing
fluidic devices.31,33
Principle of Stereolithography (SLA)
As previously mentioned, SLA depends on a photopolymerization mechanism. Resins are
either acrylate or epoxy-based and contain a photoinitiator that causes the resin to harden when
exposed to light.32,33 A digital light-processing (DLP) projector, laser, or other light source is
positioned underneath the resin reservoir. The light source transmits an image corresponding to a
single layer of the design through a clear window at the bottom of the reservoir to cure
photosensitive resin in a layer-by-layer fashion (Figure 2). The stage moves upward after each
layer is created. Each successive layer is made in the same way until the 3D object is fabricated
from bottom to top.28 Exposing the resin with a DLP projector in a layer configuration has been
reported to be faster in fabricating the object compared to laser-based curing due to the capability
of DLP to cure each successive layer of the object with single exposure steps.

Figure 2:Illustrated schematic of a DLP projector-based 3D-printer28
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Recent Developments in 3D-Printed Fluidic Devices
Fused deposition modeling (FDM) and Stereolithography (SLA), and other more
expensive 3D printing methods have recently been employed to directly print fluidic devices.
Compared to other methods of preparing fluidic devices like photolithography, 3D printing
methods hold some advantages in that they do not require multiple processing steps or unique
molds and masks for different fluidic designs, access to clean-room facilities, or large initial
capital investments in expensive equipment.32 Reproducible and reliable fabrication of fluidic
devices with truly microfluidic dimensions is often complicated by factors such as overcuring of
photopolymer resin and necessary removal of support materials included during printing
processes.32 Recently, 3D-printed fluidic channels with dimensions as small as 18 µm x 20 µm
have been fabricated by Nordin et al.29 using a DLP-SLA 3D printer and custom-formulated
resin, However, research continues to lead to improvements in printer capabilities and materials
for producing smaller fluidic devices, and millifluidic devices with channel dimensions of
hundreds of micrometers can be prepared with reasonable success for various applications.
Sensors Based on 3D Printed Fluidics
Several biosensors based on 3D-printed fluidic devices paired optical detection methods,
even some using smartphone cameras to measure optical signals,24 have been described. The
combination of 3D-printed fluidics with electrochemical detection methods has also been gaining
considerable interest for developing biosensors. The pairing of 3D printing with electrochemical
instrumentation can provide relatively inexpensive, robust and easy to operate platforms for
biosensing compatible with several important areas of need such as POCT applications and lowcost devices for resource-limited settings.20
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In 2010, Snowden et al. demonstrated one of the first approaches toward developing 3Dmicrofluidic devices for versatile electrochemical measurements. They utilized a 3D-printing
service to produce flow-cell designs based on an expensive microstereolithography (MSL)
printer and resin consisting of a proprietary mixture of polymers.34 Flow-cells consisted of
devices that featured 3-sided open-bottom channels with widths of 3 mm and heights of 200 µm,
which were placed on top of electrodes deposited on a planar surface like an Si/SiO2 wafer.
Devices featured inlet and outlet ports and a leak-proof seal was created between the electrode
substrate and the bottom of the channel simply by fastening the device and electrode substrate
together using cotton thread. Microfluidic device functionality for electrochemical measurements
was confirmed through the series of experiments using redox probes at various flow rates.
Erkal et al. developed 3D-printed devices with incorporated electrodes for
electrochemical measurement of nitric oxide (NO), oxygen tension in a stream of red blood cells,
and the neurotransmitter dopamine. Fluidic devices with channel sizes of 500 x 500 µm were
printed using an expensive Objet Connex 350 polyjet 3D printer. Electrodes were introduced into
the device through threaded ports that are compatible with commercially available fittings into
which metal wires can be inserted to serve as electrodes.22
Bishop et al. demonstrated that electrodes could similarly be incorporated in
semitransparent 3D-printed microfluidic devices produced using a very low cost FDM printer.21
The fluidic device was fabricated using transparent polyethylene terephthalate (PET) filament
and featured threaded ports to access the fluidic channel. Custom-threaded fittings for electrode
integration into the device channels were fabricated using thermoplastic polymer, acrylonitrile
butadiene styrene (ABS) since printer resolution was not sufficient to facilitate use of
commercially available fittings. Gold disk working electrodes were made of Au wire integrated
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in the ABS fitting. Prussian blue nanoparticles (PBNPs) were prepared using a separate 3Dprinted flow mixing device and deposited on Au electrodes for sensing of hydrogen peroxide
(H2O2). The 3D-printed flow devices with integrated PBNP-modified Au electrodes exhibited
excellent response towards different concentrations of H2O2 using a flow-through amperometric
method. In a separate report, Bishop et al. developed transparent fluidic devices via a desktop
DLP-SLA printer that could be interfaced with low-cost graphite electrodes through commercial
fittings and compatible printed threaded ports for electrochemiluminescence measurements of
DNA oxidation.23
Research Objectives
ELISAand other clinical techniques for measuring biomarkers proteins typically lack
sensitivity, demand high analysis cost, are often not well-suited for measuring multiple
biomarkers in a single sample, and require long analysis times. Hence, the primary goal of the
work described herein is to develop a simple, low-cost 3D-printed flow-through device with
modularly integrated electrodes to serve as a platform for electrochemical sandwich-type
immunoassays. For the biomarker protein target for immunoassay development in these studies,
we selected the protein S100B, which is a biomarker for melanoma, one of the most prevalent
forms of cancer in the United States ranking as the 5th most common cancer among men and 6th
most common among women.36 Over the past few decades, the number of new cases of
melanoma has consistently increased, and it is expected to continue to grow at a rate that is
among the highest of all cancers.37,38 Even though melanoma accounts for less than 5% of all
forms of skin cancers,39 it is responsible for the vast majority of deaths caused by the disease.36
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High levels of S100B in tissues and serum are commonly related to stage III and IV
disease and are used in national guidelines in other countries for diagnosis of melanoma.40,41,42
One study of 412 healthy individuals and 1,007 melanoma patients found the geometric mean in
sera of healthy controls to be 20 pg/mL.42 On the other hand, 12% of melanoma patients in
clinical stage I, 51% in stage II, and 79% in stage III had levels greater than 100 pg mL-1. In
another study, von Schoultz et al. analyzed 643 patient samples with varying clinical stages of
malignant melanoma. It was found that the relative risk of death increased five-fold when the
average of S100B surpassed 0.6 ng/mL.43
In working towards accomplishing the objective of demonstrating an immunosensor
platform and strategy for S100B based on 3D-printed fluidics and electrochemical detection, we
combined elements from the electrochemical 3D-printed fluidic devices described by Bishop et
al. with the detection strategy outlined by the Rusling group. In this project, a DLP projectorbased 3D printer was utilized to fabricate fluidic devices from photoactive resin with slightly
smaller limiting channel dimensions compared to those previously reported using a laser-based
SLA printer. Electrodes were made from low-cost pencil graphite and commercially available
threaded fittings. The sandwich-type electrochemical immunoassay was adapted from previous
reports from the Rusling group.18,19,46
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CHAPTER 2
EXPERIMENTAL
Chemicals and Materials
Sodium chloride, sodium phosphate dibasic, and potassium phosphate monobasic were
purchased from Acros Organics. Sulfuric acid (95-98%), potassium chloride, hydroquinone
(≥99%), hydrogen peroxide (30% wt in H2O), poly(diallyldimethylammonium chloride)
(PDDA) (20 wt% in water, Mw 350,000 to 400,000), Tween-20, and 2,2’-azino-bis(3rthylbenzothiazoline-6-sulphonic acid) (ABTS) were obtained from Sigma Aldrich. Potassium
ferricyanide, citric acid, and sodium lauryl sulfate (SLS) were from Fisher Scientific. Diagnostic
grade probumin Bovine Serum Albumin (BSA) was obtained from Millipore. Hydrochloric acid
(36.5-38%) and sodium hydroxide were acquired from VWR. Magnetic microbeads (ProMag 1)
were procured from Bangs Laboratories, Inc. N-Hydroxysuccinimide (NHS) (98+%) and 1Ethyl-3-(3-dimethylaminopropyl) carbodiimide (EDC) were obtained from Alfa Aesar.
Biotinylated peroxide, horseradish peroxidase enzyme (HRP) was supplied by Invitrogen.
Human S100B protein, S100B capture antibody, and S100B detection antibody were acquired
from R&D Systems Company. Photopolymer PR48-clear resin was procured from Autodesk.
Photopolymer B9R-4-Yellow resin was purchased from B9Creations. All solutions were
prepared using 18.2 MΩ ultrapure water, which was obtained by passing deionized water
through a Millipore Synergy UV water purification system.
Fabrication of 3D-Printed Fluidic Devices
A B9Creator v1.2 DLP projector-based SLA 3D-printer (B9 creations) (Figure 3) with
XY resolution reaches to 30 µm was used to prepare flow-cell devices, which were designed
using 123D Design computer-aided design (CAD) software (Autodesk). The fluidic device
19

design was generally based on previous work of Bishop et al.21,23 Threaded ports located at the
inlet and outlet of the channel provided means for fluid delivery using commercially available
fittings and tubing, and a threaded port in the center of the device enabled incorporation of
electrodes. The design file was processed using B9Creator software to configure printing
parameters and generate SLA instructions by slicing the 3D representation into sections of userdefined thickness along the z-axis. The resulting SLA file was uploaded to the 3D printer, and
the object was printed.

Figure 3: Photograph of B9Creator 3D-printer and illustrated representation of the printing
process. A) Photograph of 1.2v B9Creator with DLP-based projector. B) A digital representation
of the desired object is prepared using computer-aided design (CAD) software. C) Illustrated
representation of the printing process based on SLA printing with DLP-based projector

20

Electrode Fabrication
Electrodes were incorporated into commercially available fittings as has been previously
reported by Erkal et al.22 and Bishop et al.21,23, so that they could be integrated into the 3Dprinted fluidic device. Electrodes were prepared from various conductive wires or rods (0.25 or
0.50 mm in diameter) that were connected to 24-gauge copper wire (Figure 4). These wires were
inserted into the center hole of commercially available 10-24 threaded fittings such that the
conductive wires or rods were located at the bottom of the fitting opening. Empty space between
the wires and center hole of the fitting was filled with epoxy, and the fitting was polished,
resulting in disk shaped-electrodes.

Figure 4: Photographs of electrodes fabricated in commercially available fittings. Images of
electrode components (A) and assembled electrodes (B). C) Side view of assembled electrode
incorporated into transparent 3D-printed device with straight design. (D) Bottom view of
graphite working and counter electrode (stainless steel counter electrode in D)
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Each electrode fitting contained at least 3 electrodes, with at least one serving as the
working electrode, one as the reference electrode, and one as the counter electrode. Electrode
fittings featured carbon working electrodes that were fabricated using very low-cost pencil
graphite rods (0.5 mm in diameter). Silver wire (0.25 mm in diameter) and 22-gauge stainless
steel (SS) wire (0.64 mm in diameter) were used as the reference and counter electrodes,
respectively.21,22,23 For carbon and stainless-steel wire, one end of the wire was connected to 24gauge Cu wire using Ag paste to provide a low resistance of (0-0.9 Ω) prior to insertion in the
fitting. Since conductivity could be impaired by negligent manipulation of the wires, a digital
multimeter was used to verify suitable resistance before and after the wires were inserted into the
threaded fitting. For silver wire, one end of the wire was connected to 24-gauge Cu wire by
soldering to give resistance of 0 Ω. The copper wires provide a means for connecting the
electrodes to electrochemical workstations for measurements.
Electrochemical Measurements
After electrode fittings were fabricated and polished, silver disk electrodes coated with
silver chloride were used to provide a suitable quasi-reference electrode for the system. This was
achieved by connecting the silver disk electrode in the electrode fitting, which was placed in a
1.0 M HCl solution, to the anode of a 9-volt battery. The circuit was completed using a Pt wire or
other silver chloride-coated silver wire also placed in the HCl solution. All electrochemical
measurements were obtained using a CHI400 electrochemical analyzer or CHI1030C 8-channel
multi-potentiostat. Cyclic voltammetry and amperometry were used to evaluate electrode fitting
performance and complete electrochemical immunoassays.
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Electrochemical Immunoassay
The electrochemical immunoassay strategy for S100B biomarker protein was adapted
from previous work.18,19,46 The strategy generally involves nanostructuring carbon working
electrodes using electrostatic adsorption of glutathione-capped gold nanoparticles (GSH-AuNPs)
and attaching capture antibodies to the free carboxylate ends of GSH-AuNPs through amide
bond formation using EDC/NHS. The antibody-modified electrodes were integrated into the 3Dprinted flow-cell. S100B proteins were collected from the sample using magnetic beads that were
modified with antibodies and a signal-transducing enzyme label horseradish peroxidase (HRP).
The collected proteins labeled with magnetic beads were introduced into the flow-cell through a
flow injection system, where they were subsequently captured by the antibodies on the electrode
surface. Signal was generated by activating the HRP enzyme using H2O2. The activated enzyme
oxidized a small, diffusible molecule (hydroquinone), which then was reduced at the electrode
upon application of a suitable potential using an electrochemical workstation.
Nanostructuring and Modification of Electrodes with Antibodies
GSH-AuNPs (~5 nm) were prepared according to the method of Zheng et al.44 Following
previous reports by Rusling et al.,45 working electrodes were modified with GSH-AuNPs by a
simple layer-by-layer (LbL) electrostatic adsorption method (Figure 5).18,19 First, PDDA (2
mg/mL in 0.05 M NaCl) was deposited on carbon working electrodes by drop casting 2 µL of the
PDDA solution on the electrode surface.
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Figure 5: Illustrated representation of an electrode modified with gold nanoparticles using
layer-by-layer (LbL) electrostatic adsorption
After rinsing with water and drying with nitrogen, GSH-AuNPs were similarly deposited
by drop casting. After rinsing with water and drying, a mixture of EDC and NHS (375 mM/750
mM) was dropped on the electrode and allowed to sit on the electrode surface for 10 minutes to
activate carboxylate groups. After activated electrodes were rinsed and dried, S100B capture
antibodies with concentration of 240 µg/mL were then deposited on the electrode to immobilize
them through amide bond formation.
Preparation of Antibody- and Enzyme-Labeled Magnetic Beads
Magnetic beads (MBs) functionalized with detection antibodies and HRP enzyme labels
were prepared from streptavidin-coated MBs (~1 µm dia.) using a procedure that was adapted
from previous literature,18,19,46 and recommendations of the magnetic bead manufacturer.53
Briefly, 20 µL of magnetic microbeads (0.2 mg) were washed three times with 200 µL volume of
0.1 M, Phosphate Buffered Saline (PBS. pH 7.3). A magnetic bead separator that consisted of a
3D-printed microcentrifuge tube holder and neodymium magnet (K & J magnetics) (Figure 6)
was used to remove buffer after each wash, and the magnetic beads were resuspended after
addition of new buffer solution by vortexing. After the final wash, the pellet was resuspended in
24

400 µL wash buffer to give a suspension with bead concentration of 0.5 mg/mL. The washed
MBs were split into four portions of 100 µL (0.05 mg each) in separate microcentrifuge tubes.

Figure 6: Illustration representation and photographs of the process of preparing the
bioconjugate magnetic beads MBs
Biotinylated IgG detection antibody (Ab2) for S100B (5 and 20 µL of 6 µg/mL) were
mixed separately with 15 µL of 0.25 mg/mL biotin-HRP prepared by diluting commercial biotinHRP reagent ten times with 0.1M PBS. The antibody-HRP mixtures were each diluted with
0.1M PBS to give a final volume of 35 µL, and added to separate 100 µL portions of magnetic
beads. The mixtures were quickly vortexed, and put on a microcentrifuge tube rotator, which
consisted of a 3D-printed microcentrifuge tube holder attached to an electrode rotator (Figure
6B) for 45 minutes. The mixture was washed 3 times with 100 µL 0.1M PBS and beads were
separated from solution after each wash. The magnetic bead conjugates were resuspended at a
final concentration of 0.5 mg/mL in 0.1M PBS.
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Characterization of Bioconjugate MBs
To determine enzyme loading on bioconjugate MBs, an ABTS assay was performed.54
HRP standards were prepared by diluting biotin-HRP in 0.1M PBS. MB bioconjugate samples
were diluted 160x in 0.1M PBS. 40 µL of each standard and sample were placed in separate
microcentrifuge tubes and kept cold in the fridge or on ice. ABTS, 600 µL of 1 mg/mL in
phosphate citrate buffer (pH 5.0) with 0.03% hydrogen peroxide was added to each
microcentrifuge tube and incubated at room temperature for 30 minutes. The reaction was
stopped by adding 600 µL of 0.6% SLS. A blank was prepared by mixing 600 µL of phosphatecitrate and 600 µL of 0.6% SLS. Absorbance was measured at 420 nm for each reaction mixture
using Shimadzu UV-VIS instrument.
Isolation and Labeling of Protein Biomarker
The electrochemical immunoassay for S100B was completed by first isolating the protein
from the sample and labeling it with bioconjugate MBs. Magnetic beads bioconjugate, 30 µL of
0.5 mg/mL, prepared previously were mixed with 10 µL S100B biomarker protein sample or
control (ultrapure water). The resulting mixture was put on the microcentrifuge rotator for 20
minutes at 400 RPM. After mixing, beads were then washed three times with 0.1M PBS,
resuspended in 60 µL 0.1M PBS, and kept in fridge or ice until other processes have been
completed.
Flow-Injection System
While MBs were incubated with S100B sample or control, an antibody-modified
electrode was incorporated into the 3D-printed fluidic device. First, the electrodes in the fitting
were rinsed with 0.1 % bovine serum albumin (BSA) in 0.1M PBS to help block non-specific
binding of MBs on the electrode surface.45 For better sealing of the commercial fitting threads
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with the 3D-printed device threads, white Teflon tape was wrapped around the fitting, and then
electrode fittings were secured into the center port of the 3D-printed flow-cell device. Inlet and
outlet ports of the device were connected to fittings into which commercially available tubing
had been inserted. The inlet tubing was also connected to a manual injector (Rheodyne, LLC)
fitted with a 20 µL sample loop, which was in-line with a syringe pump (New Era Systems) to
serve as a flow-injection system. The flow-injection system facilitated delivery of electrolyte
solutions and reagents through the channel to the incorporated electrode. The flow rate was
typically set to 100 µL/min.
Capture of Magnetic Bead-Labeled Protein Biomarkers and Development of Electrochemical
Signal
BSA, 80 µL of 0.1 %, was loaded into sample loop, and injected under a flow of 0.05%
Tween-20 surfactant in 0.1M PBS in order to passivate the surface of the flow-cell and electrode
and reduce potential NSB. Flow was stopped for 5 minutes when BSA reached electrodes (20
seconds after injection), and flow was then resumed until the BSA was satisfactorily purged from
the sample loop. MBs exposed to S100B sample or control were then introduced into the 3Dprinted fluidic device under a flow of 0.1M PBS at rate of 100 µL/min. Again, flow was stopped,
and MBs incubated on the electrode surface for 15 minutes to facilitate binding. Flow was
resumed after the incubation step was complete to remove unbound MBs. Signal was generated
by injecting a mixture of 100 µM hydrogen peroxide and 1.0 mM hydroquinone into the sample
loop under a flow of 100 µL/min of 1.0 mM hydoquinone in order to activate the enzyme labels
on the MBs and oxidize hydroquinone. Electrochemical reduction of oxidized hydroquinone
provided a signal that was related to S100B concentration in sample being detected.

27

CHAPTER 3
RESULTS AND DISCUSSION
3D-Printed Fluidic Devices
With typical resolution of tens of micrometers in the XY dimensions and a few
micrometers to tens of micrometers in the Z dimension, SLA is among the best 3D-printing
methods for accurately producing objects with small dimensions. Two basic 3D-printed fluidic
device designs were used in these studies (Figure 7). A straight channel design featured inlet and
outlet ports that were in line with the central electrode port as previously reported by Bishop et
al.21,23 except the overall channel and device length were shorter. The straight channel was
designed to have 800 µm x 800 µm square cross-sectional channel, 4.2 cm in length, with total
internal volume ~26 µL. A U-shaped channel design with the inlet and outlet ports offset from
the central port was also tested. The U-shaped channel was designed to be 500 µm wide by 600
µm high, 3.2 cm in length, and with total internal volume ~9.6 µL. While there were no
significant differences in overall device behavior, the U-shape design provides somewhat easier
incorporation of the electrode in the device due to the extra space given by the offset between the
inlet/outlet ports and the central electrode port.

Figure 7: Illustrated representations of 3D-printed fluidic devices. A) Straight channel device.
B) U-shaped channel device
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Fluidic devices of both types were fabricated from two different photocurable resins,
PR48-clear resin and B9R-4-Yellow resin (Figure 8). All devices were printed at 50 µm XY and
50 µm Z resolution. The combination of channel design size and printing resolution enabled
production of devices with open channels. However, printing occasionally led to partially or
completely blocked channels, and in some cases, devices that were unusable. This is a common
problem with fluidic devices produced by SLA and other printing methods where materials are
initially present in the channel as it is developed.

Figure 8: Photographs and microscope images of printed devices and channels. A and B are
images of 3D-printed fluidic. C and D are microscope images of channels in 3D-printed fluidic
devices. Scale bars represent 300 µm
Cross-sectional images of open-ended channels showed good agreement between channel
design size and actual printed size (Figure 9). A straight channel designed to be 800 µm x 800
µm with total internal volume ~26 µL was found to measure 720 µm in height and 830 µm in
width. The reduced height of the printed device compared to the design is most likely caused by
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overcuring of the 50 µm z-axis sections due to bleeding of photoradiation in the z-axis during
exposure steps.

Figure 9:Microscopic images of cross-sectional view of straight channel

Electrochemical Characterization of Electrode Fittings
After fabrication of electrode fittings, the electrochemical behavior of the electrode
system was tested through cyclic voltammetry (CV) of K3[Fe(CN)6] as the redox probe at
different scan rates to confirm functionality (Figure 10). Electrodes exhibited a typical peakshaped response for ferri-/ferrocyanide redox couple showing a pair of peaks centered at 170.5
mV vs. Ag/AgCl and a peak separation of 79 mV. The CV peak current also showed a linear
relationship with the square root of the scan rate as expected, which allowed application of the
Randles-Sevcik equation to estimate the electroactive surface area of the pencil graphite working
electrodes.
𝑖& = (2.686 𝑥 100 )𝑛2/4 𝐴𝑐𝐷8/4 𝑣8/4

(1)

Where, 𝑖& corresponds to peak current (in A), 𝑛 is the number of electron transferred per mole of
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redox active species during the electrochemical reaction, 𝐴 is the electrode area (in cm2), 𝑐 is the
bulk concentration of the redox active species (in mol/cm3), 𝐷 is the diffusion coefficient (in
cm2/sec), and 𝑣 is the scan rate (in V/s).

Figure 10: Electrochemical behavior of the electrode system. A) Representative CVs of
electrode fitting in 1.0 mM K3[Fe(CN)6] in 0.1 M KCl prepared in ultrapure water at different
scan rates ranging from 10 mV/s to 100 mV/s. B) Randles-Sevcik plot for cathodic and anodic
peak currents obtained from CVs
The average electroactive surface area estimated using equation 1 was 3.1 (±0.74) x10-3
cm2 (n = 6) with a 23.7% relative standard deviation (RSD). The nominal diameter for the pencil
graphite rod used in the fabrication of each working electrode was 0.5 mm. Hence, the geometric
area of the electrode is expected to be 2 x 10-3 cm2. The discrepancy between the electroactive
surface area and the estimated geometric surface area may be indicative of surface roughness or
variations in orientation of the graphite rod in the fitting, which can result in different crosssectional electrode shapes (oval or circle). Variations in cross-sectional shape and surface
roughness can also contribute to differences in electroactive surface areas among electrodes
fabricated through the same procedure.
CVs were also obtained to ascertain electrochemical behavior of the electrode fittings in
the 3D-printed flow cell. Electrode fittings were first placed in a 10-mL beaker of the
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K3[Fe(CN)6] solution so that CV measurements could be performed. The same electrode fittings
were then incorporated into 3D-printed fluidic devices filled with the K3[Fe(CN)6] solution using
10-mL syringe; thus, CV measurements could be repeated for comparison of responses inside
and outside the channel.
There were no significant differences in peak positions or peak currents for electrodes in
the beaker compared to electrodes in the 3D-printed fluidic devices (Figure 11). These results
confirm the flow-cell system with incorporated low-cost electrodes can be used for reliable
electrochemical measurements.

Figure 11: Comparison of CVs responses of electrode fitting towards the [Fe(CN)6]3/[Fe(CN)6]4- redox couple for graphite electrodes inside and outside the 3D-printed fluidic
device. CVs were obtained in 1.0 mM potassium ferricyanide with 0.10 M KCl prepared in
ultrapure water at scan rates of 100 mV s-1. Arrows indicate the direction of scans
Flow-Through Amperometry with Electrode in 3D-Printed Device
3D-printed fluidic devices with incorporated electrodes were connected to a syringe
pump and manual injector to test compatibility with flow-through amperometry as an
electrochemical detection method (Figure 12). The electrochemical response was tested by
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injecting 20 µL of a mixture of 1.0 mM K3[Fe(CN)6] (redox probe) and 0.10 M KCl electrolyte
prepared in ultrapure water under a 100 µL/min flow of 0.10 M KCl while the electrode was held
at a potential of 0 V vs. Ag/AgCl. A peak-shaped response was generated as the redox probe is
reduced once it reaches then flows past the working electrode. After injection, 20 seconds was
required for the current to reach a value that was 10% greater than the background, and another
9-10 seconds for the current to reach a maximum of 0.28-0.30 µA.

Figure 12: Flow-through amperometry setup and representative responses. A) Illustrated
representation of the flow-through amperometry setup. The 3D-printed device with incorporated
electrode is located downstream from a manual injector and syringe pump. B) Representative
responses for 1 mM ferricyanide in 0.1 M KCl prepared in ultrapure water loaded and injected
through a 20 µL sample loop at 150 sec, 280 sec, and 380 sec under a 100 µL/min flow of 0.1 M
KCl while the working electrode was held at a potential of 0 V vs. Ag/AgCl
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Characterization of AuNP-Functionalized Pencil Graphite Working Electrodes and Modification
with Capture Antibodies
Pencil graphite working electrodes were modified with antibodies to serve as platforms
for the sandwich-type electrochemical immunoassay. Electrode modification was accomplished
through a layer-by-layer electrostatic adsorption process followed by an amide bond forming
reaction that had previously been employed to incorporate antibodies on screen-printed
carbon18,19 and pyrolytic graphite electrodes50. Glutathione (GSH)-capped AuNPs were
electrostatically adsorbed onto the pencil graphite electrode using the cationic polymer PDDA,
and carboxylate groups of GSH-AuNPs were activated with EDC/NHS so that amide bonds
could be formed with primary amines of S100B antibodies. The presence of AuNPs on the
electrode surface was confirmed using CV (Figure 13) where AuNPs get oxidized and reduced
by the following half-reaction.

3H2O + 2Auo

⇌

Au2O3 + 6H+ + 6e-

(2)

AuNP-modified electrodes exhibited an oxidation peak at 1.145 V vs. Ag/AgCl, and a
reduction peak at 0.653 V vs. Ag/AgCl in 0.5 M H2SO4, which confirms successful modification
of the electrode surface with AuNPs.18,19 Bare and PDDA-modified electrodes produced no CV
peaks.
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Figure 13: CVs of bare and AuNP-modified carbon electrodes in 0.5 M H2SO4 prepared in
ultrapure water. Scan rate is 100 mV s-1. Arrow indicates the direction and beginning of scan
Characterization of HRP Loading on MB Bioconjugate Using ABTS Assay
Two distinct MB bioconjugates with different ratios of HRP (11.8 µg HRP/mg MB and
1.3 µg HRP/mg MB) enzyme label to S100B detection antibody (Ab2) were prepared by varying
the amount of Ab2 (5 µL and 20 µL, respectively) while using the same amount of HRP (5 µL)
during the functionalization step. An ABTS assay was performed to determine the amount of
active HRP per magnetic bead (Figure 14). Absorbance at 420 nm corresponding to product
formation was linear over the range of 0 to 100 ng/mL of HRP. The amount of HRP enzyme per
bead was found to be 11.8 µg HRP/mg MB for the sample with 5 µL Ab2, while the sample with
20 µL Ab2 contained an amount of HRP enzyme per bead that was ~9 times lower at 1.3 µg
HRP/mg MB. This difference is likely the result of the competition between biotin-HRP and
biotin-Ab2 for binding sites on the streptavidin-coated MBs during the functionalization step.
Higher Ab2-to-HRP ratio during the functionalization step results in decreased HRP loading,
while lower Ab2-to-HRP ratio results in increased HRP loading.
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Figure 14: Characterization of HRP enzyme loading on magnetic beads using ABTS assay

Electrochemical Sandwich-Type Immunoassay in 3D-Printed Fluidic Device
For immunoassays, S100B was isolated from standards and labeled using Ab2-MB-HRP.
S100B-Ab2-MB-HRP was introduced to the electrode through the flow-injection system.
Hydrogen peroxide was then injected to activate (oxidize) HRP enzyme on the magnetic beads.
Activated HRP oxidizes hydroquinone to benzoquinone, so flow-through amperometric signal
proportional to the amount of S100B present on the electrode surface was generated by holding
the electrode at a potential where benzoquinone is reduced back to hydroquinone. To determine
an appropriate electrode potential for signal generation, CVs were performed on a solution of
hydroquinone prepared in 0.1M PBS (Figure 15). CVs of hydroquinone showed a pair of peaks
centered at 35 mV vs, Ag/AgCl with a peak separation of 112 mV and indicated that
benzoquinone is completely reduced to hydroquinone at potentials that are more negative than
~0 V vs. Ag/AgCl. To ensure complete reduction of enzyme-generated benzoquinone while
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avoiding the onset of current associated with other possible reactions, a potential of -0.25 V vs.
Ag/AgCl was selected for flow-through amperometry detection during the immunoassay.

Figure 15: CV of 1.0 mM hydroquinone solution prepared in 0.1M PBS taken at 50 mV/s using
electrode fitting in 3D-printed fluidic device. Scan rate is 100 mV s-1 , and the black arrow
indicated the beginning of the scan. The red arrow indicates the potential (- 0.25 V vs. Ag/AgCl)
that was selected for subsequent amperometric experiments to reduce benzoquinone generated
by the activated HRP
The basis for the immunoassay is the electrochemical reduction of benzoquinone that is
generated by activated enzyme labels. Since hydrogen peroxide, which is used to activate the
enzyme during the immunoassay, is an oxidizing agent, a false positive signal would result if
H2O2 is able to oxidize hydroquinone to benzoquinone directly or electrocatalytically with the
aid of AuNPs immobilized on the electrode surface.51 To confirm that S100B-Ab2-MB-HRP are
necessary for generation of benzoquinone from hydroquinone, flow-through amperometry was
performed using MBs bioconjugates that were mixed with 1.45 ng/mL S100B and a separate trial
that included no MB bioconjugate (only purified water) (Figure 16). Peak-shaped amperometric
signal only resulted when MB bioconjugate was present on the surface, which confirms that the
combination of H2O2 and AuNPs alone cannot oxidize hydroquinone to benzoquinone.
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Figure 16: Comparison of amperometric results obtained in the presence and absence of MB
bioconjugates. For Control, electrode was exposed to d.i. water without S100B and bioconjugate
MBs. For Sample, electrode was exposed to bioconjugate MBs that were previously mixed with
1.45 ng/mL S100B. 1 mM hydroquinone with 0.1 mM H2O2 was injected at 100 µL/min to
develop each signal. Arrow indicates that the sample was injected at 100 sec. Potential applied to
working electrode was -0.25 V vs. Ag/AgCl

The Effect of HRP Loading on Amperometric Signal
Since signal generation is dependent on the amount of HRP present on the electrode
surface due to binding of MBs, large amounts of HRP enzyme labels are desirable for this
immunoassay. However, there is a limited number of binding sites on the MB surface, and it is
necessary to also include a large number of Ab2 on the MBs in order to facilitate binding to reach
low detection limits.52 Therefore, determining suitable HRP loading parameters is crucial to
optimizing the immunoassay. To test the effects of HRP loading on flow-through amperometric
signal, immunoassays were carried out with two sets of MB bioconjugates. HRP loading on MBs
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for these two different bioconjugates were 11.8 µg HRP/mg MBs and 1.3 µg HRP/mg MBs as
determined by the ABTS assay (Figure 15). MBs were mixed with either deionized water
(control) or a 1.45 pg/mL S100B standard solution.
MBs with higher HRP loading produced larger signal for both control and sample (Figure
17). Notice that the amperometric signal exhibited by controls is non-zero even though the
controls contain no S100B. This non-zero response can be attributed to non-specific binding of
the MB bioconjugates on the electrode surface, even though steps were taken to minimize NSB.
The amperometric signal using the bioconjugate MBs with higher loading of HRP (11.8 µg
HRP/mg MB) was found to be 49.3 nA, which was ~1.47 times higher than the control response.
The amperometric signal using the bioconjugate MBs with lower loading of HRP (1.3 µg
HRP/mg MBs) was 33.7 nA, which was ~1.74 times higher than the control response. More
studies must be completed to optimize HRP and antibody loading since a large analyte response
and low NSB (represented by a low control response) are necessary to produce a sensitive
immunoassay. However, these results suggest that this strategy can be successful as a
concentration which is ~30 times lower than the detection limit reported for a commercial S100B
immunoassay55 produced a signal that is distinguishable from the control.
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Figure 17: Effect of HRP loading on amperometric response. Curves show responses obtained
using bioconjugate labels that featured 1.3 µg HRP/mg MB (red) and 11.8 µg HRP/mg MB
(blue). Signal was developed by injecting 1 mM hydroquinone with 0.1 mM H2O2 at 100 µL/min
while the working electrode was held at a potential of -0.25 V vs. Ag/AgCl
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CHAPTER 4
CONCLUSION AND FUTURE WORK
Enzyme-linked immunosorbent assays (ELISA) and other clinical techniques currently
used for measuring biomarker proteins are often lacking in sensitivity, affordability, speed of
analysis, and capability to detect multiple biomarkers in a single sample. These limitations have
sparked extensive research efforts aimed at developing simple, low-cost biosensors that are
necessary to expand the possibilities of diagnostics, especially in areas of limited resources and
for immediate, on-demand measurements.
3D printing has recently gained considerable interest as an adaptable and inexpensive
technology for production of research tools owing to its ease of operation, speed, and capability
to fabricate complex structures. The combination of 3D printed fluidics with electrochemical
detection strategies seems particularly well-suited to develop biosensors that address some of the
shortcomings of other measurement systems. In this project, we have demonstrated low-cost 3Dprinted fluidic devices with modularly integrated electrodes can be used for electrochemical
sandwich-type immunoassays for the detection of biomarker protein S100B, which is a candidate
biomarker for skin cancer and brain injuries.
A B9Creator v1.2 3D printer based on a digital light processing (DLP) projector was used
to fabricate robust and low-cost fluidic devices from yellow or transparent photocurable resin
with 500-800 µm square cross-sectional channels. These devices cost about ~$1 in material to
produce using photopolymer B9R-4-Yellow resin, and ~$0.50 using the Photopolymer PR48clear resin. Highly conductive, low cost, and reusable electrodes were fabricated from
commercially available threaded fitting and pencil rods. Fabricated electrodes cost about ~$2 all
material to produce.
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Electrochemical characterization experiments using the common redox probe potassium
ferricyanide confirmed the functionality of the low-cost electrodes and reliability of
electrochemical measurements obtained using the electrode fittings incorporated in the 3Dprinted fluidic devices. Electrochemical sandwich-type immunoassays were carried out using
this system for the biomarker protein S100B with HRP-MB-Ab2 bioconjugates serving as the
signal-transducing labels and detection based on flow-through amperometry.
Loading of HRP on the MB bioconjugates could be altered by adjusting the amount of
HRP used during MB bioconjugate preparation. The ABTS assay was used to measure HRP
loading on MB bioconjugates. Peak-shaped amperometric response only developed when HRPMB-Ab2 was present on the electrode surface, and the magnitudes of amperometric peaks were
related to S100B concentration as well as HRP loading. Further studies must be completed to
optimize HRP loading and assay conditions to reduce non-specific binding and determine
important assay characteristics like sensitivity, selectivity, and dynamic range before detection of
S100B in real patient samples can be attempted. Upon repolishing, a set of 14 electrodes gave
stable, reproducible conductivity for more than four months even after they were used for several
experiments.
While these studies were focused on demonstrating feasibility of electrochemical
immunoassays using flow-through amperometric detection in 3D-printed fluidic devices for a
single biomarker protein, simultaneous detection of multiple biomarker proteins (multiplexed
detection) is also possible using this system. To enable multiplexed biomarker detection in this
system, electrode fittings with two graphite working electrodes have been fabricated (Figure 18)
in a similar fashion to that previously demonstrated.21,22,23
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Figure 18: Photograph of two-working electrode system. Working electrodes were fabricated
from 5-10 mm long carbon (pencil graphite) rods (0.5 mm in diameter), reference electrode was
fabricated from silver wire (0.25 mm in diameter), and counter electrode was fabricated from
22-gauge stainless steel (SS) wire (0.64 mm in diameter)
The electrochemical behaviors of the two working electrodes towards common redox
probe K3[Fe(CN)6] were in agreement (Figure 19). Future efforts will be focused on further
refining multielectrode platforms for this system and conducting immunoassay measurements of
biomarker panels, where issues like cross-reactivity and electrode spacing must also be
considered.

Figure 19: CV responses of electrode fitting with two pencil graphite working electrodes. The
two working electrodes positioned in the same fitting were immersed in a solution that contained
K3[Fe(CN)6] with 0.1 M KCl prepared in ultrapure water. Scan rate was 100 mV/s. Arrow
indicates the direction and beginning of scan
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